January review for Lifecore's surgical gel:
This article was originally published in Clinica
Executive Summary
An FDA advisory panel will review Lifecore Biomedical's premarket approval (PMA) application for its Intergel adhesion prevention gel on January 12. The gel is designed to prevent surgical adhesions following gynaecological laparotomy and laparoscopy, with laparotomy procedures being the subject of the first PMA. The Chaska, Minnesota-based company will submit data from its laparoscopy clinical trial as a supplement to the PMA at a later date.